50
Participants
Start Date
August 1, 2021
Primary Completion Date
May 5, 2022
Study Completion Date
July 12, 2022
ivWatch
The second half sample size PIVC will be enrolled into an alarming group. ivWatch will monitor the PIVC insertion site collecting data and sending visual and auditory notifications of any infiltration. The goals of the study on the alarming group are: a) to estimate the notification rate (the number of detected infiltration in the studied period; b) to evaluate the extension and severity of the detected infiltration at the time of the notification, so to gather if ivWatch is helpful in early diagnosis
FPGemelliIRCCS, Rome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER